EARLY O.M. Ltd.
PrivateCompany Overview
EARLY O.M. Ltd. is a biotechnology company that develops a multi-cancer screening platform using volatile organic compound (VOC) biomarkers in urine samples.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Medical Devices
Business Model
B2B2C
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EARLY O.M. Ltd. Comparables
Compare EARLY O.M. Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TOBY, Inc. | 81% | |
| Breath Diagnostics | 78% | |
| Nevia Bio | 77% | |
EARLY O.M. Ltd. Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 82% MoM.
- Mar 3, 2026
Monthly visitors grew 1278% MoM, from 79 to 1.1K.
EARLY O.M. Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EARLY O.M. Ltd.'s valuation, stock price, and market status.